PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Hematology and Oncology, University of Cincinnati Medical Center, Cincinnati, OH.\', \'Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.\', \'Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA; Department of Medical Oncology, Centro de Câncer de Brasília (CETTRO), Brasília, DF, Brazil.\', \'Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA. Electronic address: spal@coh.org.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1078-1439(20)30651-710.1016/j.urolonc.2020.12.022
?:doi
?:hasPublicationType
?:journal
  • Urologic oncology
is ?:pmid of
?:pmid
?:pmid
  • 33451934
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Systemic therapy and COVID19: Immunotherapy and chemotherapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all